Understanding Bispecific Antibody Cell Lines
Bispecific antibodies (bsAbs) are at the forefront of therapeutic innovation, particularly in cancer treatment, offering unique dual-target mechanisms. However, their complex development presents challenges from molecular engineering to regulatory compliance. Exploring advancements in bsAb technologies reveals intricate production processes and strategic applications set to shape the future of medical therapies. Understanding Bispecific Antibody Cell Line […]
3 minute read